Reactive Robotics closes Series C for VEMO ICU mobilization robot
Reactive Robotics secured a mid-seven-figure Series C round to support its VEMO robotic assistance system for early mobilization of intensive-care patients.
Evidence notes
- The round included Bayern Kapital, High-Tech Gründerfonds, Dr. Doll Holding, TQ Group, and Henrik Schunk Beteiligungs-GmbH.
- VEMO is a robotic exoskeleton attached to ICU beds for early patient mobilization.
- The system had been in use in several hospitals since 2020.
Company context
Reactive Robotics develops robotic assistance systems for very early mobilisation of critically ill patients in intensive care units.